Global Diabetes Injection Pens Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4313256
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • AstraZeneca plc
  • Biocon Ltd.
  • Business Description
  • Eli Lilly and Company
  • Jiangsu Delfu Co.
  • Key Developments
  • MORE
Diabetes Injection Pens Market - Growth, Future Prospects and Competitive Analysis, 2017-2025, the global diabetes injection pens market was valued at US$ 5.6 Bn in 2016, and is expected to reach US$ 10.7 Mn by 2025, expanding at a CAGR of 7.2% from 2017 to 2025.

Market Insights
The global diabetes injection pens market is anticipated to progress at a considerable pace over the upcoming years due to increasing diabetes prevalence and corresponding rise in patients in need of regular insulin administration. Introduction of insulin pens and the subsequent smart insulin pens has significantly contributed to rapid proliferation of diabetes injection pens market. Furthermore, growing incidence of needlestick injury corresponding to growing users of insulin injections is additionally driving patients to opt for diabetes injection pens.

The global diabetes injection pens market is segmented based on diabetes type (type I and type II diabetes), product type (insulin pens and insulin pen needles), form (disposable and reusable) and geographical distribution. Based on geographical distribution, the global diabetes injection pens market is distributed into five major regional markets namely North America (U.S., Canada), Europe (EU7, CIS, rest of Europe), Asia Pacific (Japan, China, rest of Asia Pacific), Latin America (Brazil, Mexico, rest of Latin America) and Middle East and Africa (GCC, rest of Middle East and Africa). Among the considered regions, Europe is observed to be a saturated market with moderate movements, where introduction of breakthrough technology may bring an upswing in the market. United States is the largest revenue generating country-level market with large diabetes prevalence and better awareness and reimbursement for diabetes management. On the other hand, Asia Pacific is observed to be the fastest progressing regional market. Evolving healthcare infrastructure, improving awareness and growing healthcare expenditure majorly drive Asia Pacific diabetes injection pens market.

Overall competition in the global diabetes injection pens market is intense and it is anticipated that similar competitive environment shall prevail through the forecast period. Some of the notable players in the global diabetes injection pens market are AstraZeneca plc, Becton, Dickinson and Company, Biocon Ltd., Eli Lilly and Company, Jiangsu Delfu Co., Novo Nordisk A/S, Owen Mumford Ltd. and Wockhardt Ltd.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AstraZeneca plc
  • Biocon Ltd.
  • Business Description
  • Eli Lilly and Company
  • Jiangsu Delfu Co.
  • Key Developments
  • MORE
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase II-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Diabetes Injection Pens Market Portraiture
2.1.1. Global Diabetes Injection Pens Market, by Indication, 2016
2.1.2. Global Diabetes Injection Pens Market, by Product Type, 2016
2.1.3. Global Diabetes Injection Pens Market, by Form, 2016
2.1.4. Global Diabetes Injection Pens Market, by Geography, 2016

Chapter 3. Diabetes Injection Pens: Market Dynamics and Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.4.1. Attractive Investment Proposition, by Geography
3.5. Competitive Landscape
3.5.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Diabetes Injection Pens Market, by Indication, 2015 - 2025 (US$ Mn)
4.1. Overview
4.2. Type I Diabetes
4.3. Type Ii Diabetes

Chapter 5. Global Diabetes Injection Pens Market, by Product Type, 2015 - 2025 (US$ Mn)
5.1. Overview
5.2
5.3. Insulin Pens
5.4. Insulin Pen Needles

Chapter 6. Global Diabetes Injection Pens Market, by Form, 2015 - 2025 (US$ Mn)
6.1. Overview
6.2. Disposable
6.3. Reusable

Chapter 7. Global Diabetes Injection Pens Market, by Geography, 2015 - 2025
7.1. Overview
7.2. North America Diabetes Injection Pens Market Analysis, 2015 - 2025
7.2.1. North America Diabetes Injection Pens Market, by Indication, 2015 - 2025 (US$ Mn)
7.2.2. North America Diabetes Injection Pens Market, by Product Type, 2015 - 2025 (US$ Mn)
7.2.3. North America Diabetes Injection Pens Market, by Form, 2015 - 2025 (US$ Mn)
7.2.4. North America Diabetes Injection Pens Market, by Country, 2015 - 2025 (US$ Mn)
7.2.4.1. U.S
7.2.4.2. Canada
7.3. Europe Diabetes Injection Pens Market Analysis, 2015 - 2025
7.3.1. Europe Diabetes Injection Pens Market, by Indication, 2015 - 2025 (US$ Mn)
7.3.2. Europe Diabetes Injection Pens Market, by Product Type, 2015 - 2025 (US$ Mn)
7.3.3. Europe Diabetes Injection Pens Market, by Form, 2015 - 2025 (US$ Mn)
7.3.4. Europe Diabetes Injection Pens Market, by Region, 2015 - 2025 (US$ Mn)
7.3.4.1. E.U.7
7.3.4.2. Cis
7.3.4.3. Rest of Europe
7.4. Asia Pacific Diabetes Injection Pens Market Analysis, 2015 - 2025
7.4.1. Asia Pacific Diabetes Injection Pens Market, by Indication, 2015 - 2025 (US$ Mn)
7.4.2. Asia Pacific Diabetes Injection Pens Market, by Product Type, 2015 - 2025 (US$ Mn)
7.4.3. Asia Pacific Diabetes Injection Pens Market, by Form, 2015 - 2025 (US$ Mn)
7.4.4. Asia Pacific Diabetes Injection Pens Market, by Country, 2015 - 2025 (US$ Mn)
7.4.4.1. China
7.4.4.2. India
7.4.4.3. Rest of Apac
7.5. Latin America Diabetes Injection Pens Market Analysis, 2015 - 2025
7.5.1. Latin America Diabetes Injection Pens Market, by Indication, 2015 - 2025 (US$ Mn)
7.5.2. Latin America Diabetes Injection Pens Market, by Product Type, 2015 - 2025 (US$ Mn)
7.5.3. Latin America Diabetes Injection Pens Market, by Form, 2015 - 2025 (US$ Mn)
7.5.4. Latin America Diabetes Injection Pens Market, by Country, 2015 - 2025 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa (Mea) Diabetes Injection Pens Market Analysis, 2015 - 2025
7.6.1. Mea Bovine Diabetes Injection Pens Market, by Indication, 2015 - 2025 (US$ Mn)
7.6.2. Mea Bovine Diabetes Injection Pens Market, by Product Type, 2015 - 2025 (US$ Mn)
7.6.3. Mea Bovine Diabetes Injection Pens Market, by Form, 2015 - 2025 (US$ Mn)
7.6.4. Mea Bovine Diabetes Injection Pens Market, by Region, 2015 - 2025 (US$ Mn)
7.6.4.1. Gcc
7.6.4.2. Rest of Mea

Chapter 8. Company Profiles
8.1. Astrazeneca Plc
8.1.1. Business Description
8.1.2. Financial Information (Subject to Data Availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Becton, Dickinson and Company
8.3. Biocon Ltd
8.4. Eli Lilly and Company
8.5. Jiangsu Delfu Co
8.6. Novo Nordisk A/S
8.7. Owen Mumford Ltd
8.8. Wockhardt Ltd
8.9. Other Notable Players

List of Figures
Figure 1 Diabetes Injection Pens: Market Segmentation
Figure 2 Global Diabetes Injection Pens Market, by Indication, 2016 (US$ Mn)
Figure 3 Global Diabetes Injection Pens Market, by Product Type, 2016 (US$ Mn)
Figure 4 Global Diabetes Injection Pens Market, by Form, 2016 (US$ Mn)
Figure 5 Global Diabetes Injection Pens Market, by Geography, 2016 (Value %)
Figure 6 Attractive Investment Proposition, by Geography
Figure 7 Market Competition Landscape, by Key Players, 2016
Figure 8 Global Diabetes Injection Pens for Type I Diabetes Market, 2015 - 2025 (US$ Mn)
Figure 9 Global Diabetes Injection Pens for Type Ii Diabetes Market, 2015 - 2025 (US$ Mn)
Figure 10 Global Insulin Pens Market, 2015 - 2025 (US$ Mn)
Figure 11 Global Insulin Pen Needles Market, 2015 - 2025 (US$ Mn)
Figure 12 Global Disposable Diabetes Injection Pens Market, 2015 - 2025 (US$ Mn)
Figure 13 Global Reusable Diabetes Injection Pens Market 2015 - 2025 (US$ Mn)

List of Tables
Table 1 Global Diabetes Injection Pens Market, by Indication, 2015 - 2025 (US$ Mn)
Table 2 Global Diabetes Injection Pens Market, by Product Type, 2015 - 2025 (US$ Mn)
Table 3 Global Diabetes Injection Pens Market, by Form, 2015 - 2025 (US$ Mn)
Table 4 North America Diabetes Injection Pens Market, by Indication, 2015 - 2025 (US$ Mn)
Table 5 North America Diabetes Injection Pens Market, by Product Type, 2015 - 2025 (US$ Mn)
Table 6 North America Diabetes Injection Pens Market, by Form, 2015 - 2025 (US$ Mn)
Table 7 North America Diabetes Injection Pens Market, by Country, 2015 - 2025 (US$ Mn)
Table 8 Europe Bovine Diabetes Injection Pens Market, by Indication, 2015 - 2025 (US$ Mn)
Table 9 Europe Diabetes Injection Pens Market, by Product Type, 2015 - 2025 (US$ Mn)
Table 10 Europe Diabetes Injection Pens Market, by Form, 2015 - 2025 (US$ Mn)
Table 11 Europe Diabetes Injection Pens Market, by Country, 2015 - 2025 (US$ Mn)
Table 12 Asia Pacific Diabetes Injection Pens Market, by Indication, 2015 - 2025 (US$ Mn)
Table 13 Asia Pacific Diabetes Injection Pens Market, by Product Type, 2015 - 2025 (US$ Mn)
Table 14 Asia Pacific Diabetes Injection Pens Market, by Form, 2015 - 2025 (US$ Mn)
Table 15 Asia Pacific Diabetes Injection Pens Market, by Country, 2015 - 2025 (US$ Mn)
Table 16 Latin America Diabetes Injection Pens Market, by Indication, 2015 - 2025 (US$ Mn)
Table 17 Latin America Diabetes Injection Pens Market, by Product Type, 2015 - 2025 (US$ Mn)
Table 18 Latin America Diabetes Injection Pens Market, by Form, 2015 - 2025 (US$ Mn)
Table 19 Latin America Diabetes Injection Pens Market, by Country, 2015 - 2025 (US$ Mn)
Table 20 Middle East and Africa Diabetes Injection Pens Market, by Indication, 2015 - 2025 (US$ Mn)
Table 21 Middle East and Africa Diabetes Injection Pens Market, by Product Type, 2015 - 2025 (US$ Mn)
Table 22 Middle East and Africa Diabetes Injection Pens Market, by Form, 2015 - 2025 (US$ Mn)
Table 23 Middle East and Africa Diabetes Injection Pens Market, by Country, 2015 - 2025 (US$ Mn)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AstraZeneca plc
  • Business Description
  • Financial Information (Subject to data availability)
  • Product Portfolio
  • Key Developments
  • Becton, Dickinson and Company
  • Biocon Ltd.
  • Eli Lilly and Company
  • Jiangsu Delfu Co.
  • Novo Nordisk A/S
  • Owen Mumford Ltd.
  • Wockhardt Ltd.
  • Other Notable Players
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll